PT100155A - Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas - Google Patents
Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticasInfo
- Publication number
- PT100155A PT100155A PT100155A PT10015592A PT100155A PT 100155 A PT100155 A PT 100155A PT 100155 A PT100155 A PT 100155A PT 10015592 A PT10015592 A PT 10015592A PT 100155 A PT100155 A PT 100155A
- Authority
- PT
- Portugal
- Prior art keywords
- camptotecin
- medication
- pharmaceutical compositions
- non small
- analog compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 201000009030 Carcinoma Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002685 pulmonary effect Effects 0.000 title 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65893791A | 1991-02-21 | 1991-02-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT100155A true PT100155A (pt) | 1993-05-31 |
| PT100155B PT100155B (pt) | 1999-09-30 |
Family
ID=24643331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT100155A PT100155B (pt) | 1991-02-21 | 1992-02-21 | Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5756512A (pt) |
| EP (1) | EP0572549B1 (pt) |
| JP (1) | JP2738979B2 (pt) |
| KR (1) | KR930702984A (pt) |
| AT (1) | ATE227991T1 (pt) |
| AU (2) | AU1531992A (pt) |
| CA (1) | CA2103707C (pt) |
| DE (1) | DE69232852T2 (pt) |
| DK (1) | DK0572549T3 (pt) |
| ES (1) | ES2187500T3 (pt) |
| MX (1) | MX9200755A (pt) |
| PT (1) | PT100155B (pt) |
| WO (1) | WO1992014471A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7732996A (en) * | 1995-11-22 | 1997-06-11 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
| US6096336A (en) * | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
| US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| CA2946538A1 (en) | 2014-04-04 | 2015-10-08 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
-
1992
- 1992-02-07 CA CA002103707A patent/CA2103707C/en not_active Expired - Fee Related
- 1992-02-07 JP JP4507270A patent/JP2738979B2/ja not_active Expired - Fee Related
- 1992-02-07 DK DK92907467T patent/DK0572549T3/da active
- 1992-02-07 ES ES92907467T patent/ES2187500T3/es not_active Expired - Lifetime
- 1992-02-07 AT AT92907467T patent/ATE227991T1/de not_active IP Right Cessation
- 1992-02-07 WO PCT/US1992/001034 patent/WO1992014471A1/en not_active Ceased
- 1992-02-07 AU AU15319/92A patent/AU1531992A/en not_active Abandoned
- 1992-02-07 KR KR1019930702491A patent/KR930702984A/ko not_active Ceased
- 1992-02-07 EP EP92907467A patent/EP0572549B1/en not_active Expired - Lifetime
- 1992-02-07 DE DE69232852T patent/DE69232852T2/de not_active Expired - Fee Related
- 1992-02-21 PT PT100155A patent/PT100155B/pt not_active IP Right Cessation
- 1992-02-21 MX MX9200755A patent/MX9200755A/es unknown
-
1995
- 1995-12-14 AU AU40427/95A patent/AU699436B2/en not_active Ceased
-
1996
- 1996-07-16 US US08/699,046 patent/US5756512A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0572549A1 (en) | 1993-12-08 |
| AU1531992A (en) | 1992-09-15 |
| WO1992014471A1 (en) | 1992-09-03 |
| AU4042795A (en) | 1996-02-22 |
| EP0572549B1 (en) | 2002-11-20 |
| CA2103707C (en) | 2003-12-09 |
| DE69232852D1 (de) | 2003-01-02 |
| ES2187500T3 (es) | 2003-06-16 |
| DE69232852T2 (de) | 2003-09-04 |
| ATE227991T1 (de) | 2002-12-15 |
| JP2738979B2 (ja) | 1998-04-08 |
| PT100155B (pt) | 1999-09-30 |
| CA2103707A1 (en) | 1992-08-22 |
| KR930702984A (ko) | 1993-11-29 |
| MX9200755A (es) | 1992-08-01 |
| HK1012267A1 (en) | 1999-07-30 |
| US5756512A (en) | 1998-05-26 |
| DK0572549T3 (da) | 2003-01-06 |
| EP0572549A4 (pt) | 1994-01-12 |
| AU699436B2 (en) | 1998-12-03 |
| JPH06505741A (ja) | 1994-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2080837T5 (es) | Uso de acido hialuronico en combinacion con acido ascorbico, agentes antitumorales y/o faine para el tratamiento del cancer. | |
| ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
| PT101061A (pt) | Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais | |
| SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
| ATE231863T1 (de) | 6-amino-purinderivate mit pde-iv inhibierender wirkung | |
| ES2150496T3 (es) | Cicloalquilimidazopiridinas condensadas. | |
| SE8504967L (sv) | Farmaceutisk komposition och forfarande for behandling av kroppen | |
| ES2156839T1 (es) | Medicamento que contiene alginato e implante para tratar la fibrosis. | |
| ATE177640T1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
| BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
| DK1071439T3 (da) | Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis | |
| ES2084579T3 (es) | Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol. | |
| HU213677B (en) | Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| PT100155A (pt) | Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas | |
| DE2962580D1 (en) | 7-phenyl-quinolizidine derivatives (i), their preparation, pharmaceutical compositions containing them and (i) for use in treating diseases | |
| ES499363A0 (es) | Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles | |
| ES8603270A1 (es) | Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables | |
| ES2031462T3 (es) | Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. | |
| EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
| ZA837972B (en) | Method of analgesic treatment and pharmaceutical compositions | |
| PT98538A (pt) | Processo de preparacao de factor de crescimento humano epidermico (hegf) dos seus congeneres e de composicoes farmaceuticas que os contem | |
| BR0015329A (pt) | Uso de óxido nìtrico para o tratamento de constrição das vias aéreas | |
| ZA79197B (en) | Pharmaceutical compositions and their use in the profylaxis and/or treatment of certain diseases | |
| ES2087178T3 (es) | Disulfato de ws7622a, procedimiento para su preparacion y su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19930122 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19990622 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20091222 |